In the present study, we systematically assessed modulating factors of the Aβ to p-tau axis, i.e., a potentially critical driver of tau fibrillization in AD (Pichet Binette et al, 2022), to better understand heterogeneity in pathophysiological disease progression. Here, MAPT is linked to Alzheimer disease.